Oruka Therapeutics (ORKA) Cash from Investing Activities (QoQ) (2011 - 2026)
Oruka Therapeutics (ORKA) Cash from Investing Activities (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Oruka Therapeutics | 949.58 Mn | 118.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.44% |
| Dec 31, 2025 | 82.02% |
| Sep 30, 2025 | -2,619.53% |
| Jun 30, 2025 | -88.66% |
| Mar 31, 2025 | 112.99% |
| Dec 31, 2024 | -192,856.73% |
| Mar 31, 2022 | 71.43% |
| Dec 31, 2021 | 50.00% |
| Sep 30, 2021 | 12.50% |
| Jun 30, 2021 | -166.67% |
| Mar 31, 2021 | 53.85% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | -50.00% |
| Mar 31, 2018 | -35.80% |
| Dec 31, 2017 | 609.55% |
| Sep 30, 2017 | -115.28% |
| Jun 30, 2017 | 102.83% |
| Mar 31, 2017 | -4.45% |
| Dec 31, 2016 | 223.55% |
| Sep 30, 2016 | 78.43% |